share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer MALIK AAMIR

輝瑞 | 4:持股變動聲明-高管 MALIK AAMIR
美股SEC公告 ·  09/03 18:12

Moomoo AI 已提取核心訊息

On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
On August 31, 2024, Pfizer Inc. Executive Vice President Aamir Malik completed a sale of 20,195 shares of the company's common stock. The transaction was executed at a price of $29.01 per share, resulting in a total sale value of approximately $585,857. Following the sale, Malik's direct holdings in Pfizer common stock amounted to 29,548 shares. The sale was reported as a means to cover the exercise price or tax liability by delivering or withholding securities, according to the transaction code description.
2024年8月31日,輝瑞公司執行副總裁Aamir Malik以每股29.01美元的價格完成了對公司普通股20,195股的出售。此次交易的總銷售額約爲585,857美元。出售之後,Malik在輝瑞普通股的直接持股量爲29,548股。根據交易代碼說明,此次出售報告是爲了支付行權價格或稅務責任而交付或扣留證券。
2024年8月31日,輝瑞公司執行副總裁Aamir Malik以每股29.01美元的價格完成了對公司普通股20,195股的出售。此次交易的總銷售額約爲585,857美元。出售之後,Malik在輝瑞普通股的直接持股量爲29,548股。根據交易代碼說明,此次出售報告是爲了支付行權價格或稅務責任而交付或扣留證券。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息